A dendritic cell vaccine personalised for each individual based on the patient's own tumour may increase median survival time in those with a deadly form of brain cancer called glioblastoma,…
Mutations in three pathways important for suppressing tumours cooperate to launch glioblastoma, an aggressive brain tumour that strikes children and adults. But new research from St.…
The Massachusetts General Hospital (MGH) research team that first discovered tumour-associated RNA in tiny membrane-enclosed sacs released into the bloodstream by cancer cells has now…
Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked…
New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumours if equipped with an enzyme that helps…
A study fast-tracked for online publication Dec. 22 in the New England Journal of Medicine has identified an important gene deletion in up to one of every four cases of glioblastoma,…
For patients with glioma, the most common primary brain tumour, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified…
Researchers at Mayo Clinic in Florida have found that a molecule long believed to be a beneficial tumour suppressor - and thus a potential cancer drug target - appears to act as an…
A vaccine that turns the immune system against brain tumour cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients…
A new vaccine added to standard therapy appears to offer a survival advantage for patients suffering from glioblastoma (GBM), the most deadly form of brain cancer, according to a study…